Cargando…
Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial
PURPOSE: In terms of medical policy for cervical cancer prevention, Japan lags far behind other industrialized countries. We initiated a randomized controlled trial to evaluate the self-sampling human papillomavirus (HPV) test as a tool to raise screening uptake and detection of pre-cancer. This stu...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249862/ https://www.ncbi.nlm.nih.gov/pubmed/37289798 http://dx.doi.org/10.1371/journal.pone.0286909 |
_version_ | 1785055635233046528 |
---|---|
author | Fujita, Misuzu Nagashima, Kengo Shimazu, Minobu Suzuki, Misae Tauchi, Ichiro Sakuma, Miwa Yamamoto, Setsuko Hanaoka, Hideki Shozu, Makio Tsuruoka, Nobuhide Kasai, Tokuzo Hata, Akira |
author_facet | Fujita, Misuzu Nagashima, Kengo Shimazu, Minobu Suzuki, Misae Tauchi, Ichiro Sakuma, Miwa Yamamoto, Setsuko Hanaoka, Hideki Shozu, Makio Tsuruoka, Nobuhide Kasai, Tokuzo Hata, Akira |
author_sort | Fujita, Misuzu |
collection | PubMed |
description | PURPOSE: In terms of medical policy for cervical cancer prevention, Japan lags far behind other industrialized countries. We initiated a randomized controlled trial to evaluate the self-sampling human papillomavirus (HPV) test as a tool to raise screening uptake and detection of pre-cancer. This study was conducted to explore the acceptability and preference of self-sampling using a subset of the data from this trial. METHODS: A pre-invitation letter was sent to eligible women, aged 30−59 years who had not undergone cervical cancer screening for three or more years. After excluding those who declined to participate in this trial, the remaining women were assigned to the self-sampling and control groups. A second invitation letter was sent to the former group, and those wanting to undergo the self-sampling test ordered the kit. A self-sampling HPV kit, consent form, and a self-administered questionnaire were sent to participants who ordered the test. RESULTS: Of the 7,340 participants in the self-sampling group, 1,196 (16.3%) administered the test, and 1,192 (99.7%) answered the questionnaire. Acceptability of the test was favorable; 75.3−81.3% of participants agreed with positive impressions (easy, convenient, and clarity of instruction), and 65.1−77.8% disagreed with negative impressions (painful, uncomfortable, and embarrassing). However, only 21.2% were confident in their sampling procedure. Willingness to undergo screening with a self-collected sample was significantly higher than that with a doctor-collected sample (89.3% vs. 49.1%; p<0.001). Willingness to undergo screening with a doctor-collected sample was inversely associated with age and duration without screening (both p<0.001), but that with a self-collected sample was not associated. CONCLUSIONS: Among women who used the self-sampling HPV test, high acceptability was confirmed, while concerns about self-sampling procedures remained. Screening with a self-collected sample was preferred over a doctor-collected sample and the former might alleviate disparities in screening rates. |
format | Online Article Text |
id | pubmed-10249862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-102498622023-06-09 Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial Fujita, Misuzu Nagashima, Kengo Shimazu, Minobu Suzuki, Misae Tauchi, Ichiro Sakuma, Miwa Yamamoto, Setsuko Hanaoka, Hideki Shozu, Makio Tsuruoka, Nobuhide Kasai, Tokuzo Hata, Akira PLoS One Research Article PURPOSE: In terms of medical policy for cervical cancer prevention, Japan lags far behind other industrialized countries. We initiated a randomized controlled trial to evaluate the self-sampling human papillomavirus (HPV) test as a tool to raise screening uptake and detection of pre-cancer. This study was conducted to explore the acceptability and preference of self-sampling using a subset of the data from this trial. METHODS: A pre-invitation letter was sent to eligible women, aged 30−59 years who had not undergone cervical cancer screening for three or more years. After excluding those who declined to participate in this trial, the remaining women were assigned to the self-sampling and control groups. A second invitation letter was sent to the former group, and those wanting to undergo the self-sampling test ordered the kit. A self-sampling HPV kit, consent form, and a self-administered questionnaire were sent to participants who ordered the test. RESULTS: Of the 7,340 participants in the self-sampling group, 1,196 (16.3%) administered the test, and 1,192 (99.7%) answered the questionnaire. Acceptability of the test was favorable; 75.3−81.3% of participants agreed with positive impressions (easy, convenient, and clarity of instruction), and 65.1−77.8% disagreed with negative impressions (painful, uncomfortable, and embarrassing). However, only 21.2% were confident in their sampling procedure. Willingness to undergo screening with a self-collected sample was significantly higher than that with a doctor-collected sample (89.3% vs. 49.1%; p<0.001). Willingness to undergo screening with a doctor-collected sample was inversely associated with age and duration without screening (both p<0.001), but that with a self-collected sample was not associated. CONCLUSIONS: Among women who used the self-sampling HPV test, high acceptability was confirmed, while concerns about self-sampling procedures remained. Screening with a self-collected sample was preferred over a doctor-collected sample and the former might alleviate disparities in screening rates. Public Library of Science 2023-06-08 /pmc/articles/PMC10249862/ /pubmed/37289798 http://dx.doi.org/10.1371/journal.pone.0286909 Text en © 2023 Fujita et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Fujita, Misuzu Nagashima, Kengo Shimazu, Minobu Suzuki, Misae Tauchi, Ichiro Sakuma, Miwa Yamamoto, Setsuko Hanaoka, Hideki Shozu, Makio Tsuruoka, Nobuhide Kasai, Tokuzo Hata, Akira Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial |
title | Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial |
title_full | Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial |
title_fullStr | Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial |
title_full_unstemmed | Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial |
title_short | Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial |
title_sort | acceptability of self-sampling human papillomavirus test for cervical cancer screening in japan: a questionnaire survey in the access trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249862/ https://www.ncbi.nlm.nih.gov/pubmed/37289798 http://dx.doi.org/10.1371/journal.pone.0286909 |
work_keys_str_mv | AT fujitamisuzu acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial AT nagashimakengo acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial AT shimazuminobu acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial AT suzukimisae acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial AT tauchiichiro acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial AT sakumamiwa acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial AT yamamotosetsuko acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial AT hanaokahideki acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial AT shozumakio acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial AT tsuruokanobuhide acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial AT kasaitokuzo acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial AT hataakira acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial |